Selenium: What Your Number Changes About Your Treatment

What Selenium Actually Does in the Body

Selenium is a trace mineral that the body incorporates into 25 distinct selenoproteins, each performing a specific enzymatic function. The two most clinically relevant families are the glutathione peroxidases (GPx1 through GPx4), which neutralize hydrogen peroxide and lipid hydroperoxides, and the iodothyronine deiodinases (DIO1, DIO2, DIO3), which convert thyroid hormones between their active and inactive forms 1.

The thyroid gland contains more selenium per gram of tissue than any other organ. DIO2 converts thyroxine (T4) into the biologically active triiodothyronine (T3). Without adequate selenium, this conversion slows. A 2014 systematic review in Clinical Endocrinology (N=1,013 across nine trials) found that selenium supplementation in autoimmune thyroiditis patients reduced thyroid peroxidase antibody (TPOAb) titers by a weighted mean of 271 IU/mL compared to controls 2. That antibody reduction did not always translate into improved TSH or free T4, which matters for treatment decisions.

Selenoprotein P (SePP) serves as the primary selenium transport protein and accounts for roughly 60% of plasma selenium. Some clinicians now order SePP alongside serum selenium to distinguish true tissue-level depletion from a transient dietary dip 3. SePP plateaus when serum selenium reaches approximately 125 ng/mL, a threshold the European Food Safety Authority uses when modeling adequate intake 4.

The Reference Range and Why "Normal" Is Not Always Optimal

Most U.S. laboratories report a serum selenium reference range of 70 to 150 ng/mL. That range captures the central 95% of a healthy population. It does not tell you where selenoprotein activity is maximized.

GPx activity plateaus at a serum selenium of about 90 to 100 ng/mL. SePP plateaus higher, near 125 ng/mL. A patient at 75 ng/mL sits inside the reference range but may have suboptimal GPx and SePP saturation 5. For patients on levothyroxine who still report fatigue despite a "normal" TSH, a selenium level in the low-normal zone (70 to 90 ng/mL) could explain persistent symptoms if DIO2-mediated conversion is underperforming.

The 2023 American Thyroid Association (ATA) guidelines note that selenium supplementation "cannot be universally recommended" for Hashimoto thyroiditis but acknowledge the TPOAb-lowering evidence and suggest clinician discretion when selenium levels sit below 100 ng/mL 6. That distinction between population-level reference ranges and individual functional targets is where treatment adjustments live.

Geographic variation adds another layer. Soil selenium content varies dramatically: the U.S. Great Plains grows high-selenium crops, while parts of the Pacific Northwest, Northern Europe, and large swaths of China produce selenium-poor food. A patient eating locally sourced food in a low-selenium region may test at 65 ng/mL without any malabsorption pathology.

When a Low Selenium Level Changes Your Protocol

A serum selenium below 70 ng/mL qualifies as deficiency. Below 50 ng/mL, the clinical picture shifts from subclinical to potentially symptomatic: fatigue, brain fog, muscle weakness, recurrent infections, and impaired thyroid function can all emerge.

Three clinical scenarios warrant action when selenium is low.

Thyroid hormone optimization. Patients on T4 monotherapy (levothyroxine) who have a persistently elevated T4:T3 ratio despite adequate TSH may benefit from selenium repletion before adding liothyronine (T3). The CATALYST trial (N=472), a 2024 randomized controlled trial from Denmark published in The Lancet Diabetes & Endocrinology, tested 200 mcg/day selenomethionine versus placebo in autoimmune thyroiditis patients 7. At 12 months, selenium reduced TPOAb by a mean of 21% relative to placebo. Thyroid function tests (TSH, free T4) did not change significantly, but quality-of-life scores in the selenium arm improved in the subgroup with baseline selenium below 90 ng/mL.

Antioxidant defense in metabolic disease. Patients with non-alcoholic fatty liver disease (NAFLD/MASLD) or insulin resistance carry higher oxidative stress burdens. GPx requires selenium as a cofactor. A 2017 cross-sectional analysis in Nutrients (N=3,769) found that individuals in the lowest quartile of serum selenium (<85 ng/mL) had 1.56 times the odds of metabolic syndrome compared with those in the third quartile (95 to 110 ng/mL) 8.

Immune modulation. Selenium deficiency impairs both innate and adaptive immunity. The Keshan disease epidemic in selenium-depleted regions of China demonstrated that cardiomyopathy could be prevented with selenium supplementation at 200 mcg/day 9. While Keshan disease is rare outside endemic areas, patients with chronic viral infections or autoimmune conditions may see measurable immune parameter shifts when selenium is repleted from below 70 ng/mL to above 100 ng/mL.

Standard repletion protocols use 100 to 200 mcg/day of selenomethionine (the organic, food-form selenium). Selenite (inorganic sodium selenite) is less efficiently absorbed and more likely to cause gastrointestinal side effects 10. Recheck serum selenium at 8 to 12 weeks. The goal is 100 to 130 ng/mL, not maximum.

When a High Selenium Level Changes Your Protocol

Selenium toxicity (selenosis) begins to appear at serum concentrations above 400 ng/mL, though symptoms can surface earlier in sensitive individuals. The tolerable upper intake level set by the National Institutes of Health Office of Dietary Supplements is 400 mcg/day from all sources 11.

Early signs of excess include garlic-like breath odor, brittle nails, hair loss, nausea, and peripheral neuropathy. A 2010 incident report documented 201 cases of acute selenosis from a manufacturing error in a liquid supplement that delivered 200 times the labeled dose 12. Affected individuals had serum selenium levels ranging from 500 to over 1 to 300 ng/mL. Hair loss occurred in 72% of cases. Fatigue persisted for months.

The SELECT trial (Selenium and Vitamin E Cancer Prevention Trial, N=35,533), published in JAMA in 2009, tested 200 mcg/day L-selenomethionine for prostate cancer prevention 13. The trial found no cancer prevention benefit. A 2014 follow-up analysis revealed that men in the highest quartile of baseline toenail selenium who received selenium supplementation had a statistically significant 91% increased risk of high-grade prostate cancer (HR 1.91 to 95% CI 1.21 to 3.02) 14. Dr. Alan Kristal, the lead author, stated: "Selenium supplements are not just unhelpful in preventing prostate cancer in men who are already selenium-replete. They may actually cause harm."

This finding reshaped clinical practice. If a patient's serum selenium is already above 120 to 130 ng/mL, adding supplemental selenium is not benign. The protocol adjustment is straightforward: discontinue selenium supplements, recheck in 8 to 12 weeks, and confirm levels are falling. For patients consuming Brazil nuts daily (each nut contains 70 to 90 mcg selenium), reducing intake to two nuts every other day typically brings levels into the target zone within six weeks.

How Selenium Interacts with Thyroid and Hormone Protocols

The intersection of selenium with thyroid replacement therapy is where this lab value most frequently alters prescribing. Three specific mechanisms are involved.

T4-to-T3 conversion efficiency. DIO2 is selenium-dependent. When selenium is depleted, T4 accumulates and T3 falls, even while TSH remains within range. Patients on levothyroxine who exhibit this pattern (high-normal free T4, low-normal free T3, normal TSH) should have selenium checked before their clinician considers adding liothyronine. Repleting selenium from 70 to 120 ng/mL may restore adequate conversion without the dosing complexity that comes with combination T4/T3 therapy 15.

TPOAb reduction in Hashimoto thyroiditis. The pooled evidence from the 2014 Cochrane review and subsequent trials shows that 200 mcg/day selenomethionine consistently reduces TPOAb titers over 3 to 12 months 16. Whether this translates to slower disease progression or delayed hypothyroidism onset remains unproven. The Endocrine Society's 2023 position acknowledges the antibody data but stops short of a formal recommendation, calling it "an area of active investigation."

GLP-1 receptor agonist and TRT protocols. Patients on semaglutide or tirzepatide who are losing weight rapidly may develop micronutrient depletion, including selenium, due to reduced food intake 17. A serum selenium check at baseline and at 6-month intervals during GLP-1 therapy can catch depletion before it impairs thyroid conversion or antioxidant defenses. For men on testosterone replacement therapy, selenium's role in spermatogenesis (via selenoprotein GPx4 in sperm mitochondria) may matter if fertility preservation is a goal 18.

How to Raise a Low Selenium Level

Dietary intervention is first-line for mild deficiency (60 to 85 ng/mL). Two Brazil nuts daily provide approximately 140 mcg of selenium, enough to saturate SePP in most adults within four to six weeks 19. A 2008 randomized trial in the American Journal of Clinical Nutrition (N=59) showed that two Brazil nuts per day raised plasma selenium by 64.2% and GPx activity by 13.2% over 12 weeks, matching the effect of a 100-mcg selenomethionine supplement.

For moderate to severe deficiency (below 60 ng/mL) or in patients with malabsorption (celiac disease, short bowel syndrome, bariatric surgery), supplementation at 200 mcg/day selenomethionine is standard. Selenomethionine integrates into body proteins in place of methionine, creating a selenium reserve. Sodium selenite does not build this reserve 20.

Do not exceed 200 mcg/day from supplements without monitoring. Recheck serum selenium in 8 to 12 weeks. If the level has not risen above 90 ng/mL despite adherence, evaluate for malabsorption, check albumin (selenium binds to albumin and SePP for transport), and consider divided dosing (100 mcg twice daily with meals).

Foods ranked by selenium density per serving: Brazil nuts (70 to 90 mcg per nut), yellowfin tuna (92 mcg per 3 oz), halibut (47 mcg per 3 oz), sardines (45 mcg per 3 oz), grass-fed beef (33 mcg per 3 oz), turkey (31 mcg per 3 oz), eggs (20 mcg per large egg). Soil selenium varies so dramatically that the selenium content of wheat, rice, and vegetables is unreliable without regional data.

How to Lower Selenium When It Is Too High

The body does not have a rapid excretion mechanism for selenium. Reducing intake is the only reliable approach.

Stop all selenium-containing supplements immediately. Audit the patient's supplement stack: many multivitamins contain 55 to 100 mcg selenium, and thyroid-support formulas often add another 100 to 200 mcg. Stacking these with Brazil nut consumption can push daily intake above 500 mcg.

Remove or reduce Brazil nuts. No other common food delivers enough selenium per serving to cause toxicity on its own. Seafood and organ meats contribute meaningful amounts, but a patient would need to eat several servings daily to maintain toxic levels from these sources alone.

Recheck in 8 to 12 weeks. Selenium's biological half-life varies by form: selenomethionine stored in muscle and organ proteins has a half-life of roughly 252 days, while selenite-derived pools clear in weeks 21. If levels remain elevated despite supplement cessation, investigate occupational exposure (glass manufacturing, electronics, agriculture) and well water selenium content, particularly in seleniferous regions of the western U.S.

There is no chelation therapy recommended for moderate selenosis. For acute toxicity (serum selenium above 1 to 000 ng/mL with neurological symptoms), hospital-based supportive care with monitoring of hepatic and renal function is the standard approach.

The Decision Framework: What to Do at Each Level

Your serum selenium result maps to a specific set of clinical actions.

Below 50 ng/mL (severe deficiency). Supplement with 200 mcg/day selenomethionine. Check for malabsorption. Recheck thyroid panel alongside selenium at 8 to 12 weeks. Do not start combination T4/T3 therapy until selenium is repleted.

50 to 70 ng/mL (mild deficiency). Supplement with 100 to 200 mcg/day or add two Brazil nuts daily. Prioritize repletion before attributing persistent hypothyroid symptoms to inadequate levothyroxine dosing.

70 to 100 ng/mL (low-normal). Consider targeted supplementation at 100 mcg/day if TPOAb is elevated or if the T4:T3 ratio suggests impaired conversion. Monitor but do not treat if thyroid function and antibodies are normal.

100 to 130 ng/mL (optimal functional range). No supplementation needed. Maintain dietary selenium intake. Recheck annually or with thyroid panels.

130 to 150 ng/mL (upper normal). Discontinue any selenium supplements. Reduce Brazil nut intake to two per week. No acute risk, but the SELECT data argue against supplementing in this range.

Above 150 ng/mL (elevated). Stop all supplemental selenium. Audit diet and occupational exposure. Recheck in 8 to 12 weeks. Screen for early selenosis symptoms (nail changes, hair thinning, GI complaints).

Above 400 ng/mL (toxic). Immediate supplement cessation. Clinical evaluation for neuropathy, hepatotoxicity. Consider referral to toxicology if symptomatic. As Dr. Margaret Rayman, Professor of Nutritional Medicine at the University of Surrey, has written: "Selenium has a narrow therapeutic window. The difference between a beneficial and a harmful intake is smaller than for most other essential trace elements" 22.

The recheck interval for any protocol change involving selenium is 8 to 12 weeks, the time needed for selenoprotein pools to reach a new steady state.